Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model
Lexun Wang, Huijuan Wu, Yanyue Deng, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 25

Showing 25 citing articles:

Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications
Haixia Zhang, Ke Yang, Feng Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 82
The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications
Fatin Farhana Jubaidi, Satirah Zainalabidin, Izatus Shima Taib, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8582-8582
Open Access | Times Cited: 54
Metaflammation in glucolipid metabolic disorders: Pathogenesis and treatment
Pingjie Xiong, Fan Zhang, Fang Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114545-114545
Open Access | Times Cited: 27
The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation
Meiling Yan, Lun Li, Qing Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112709-112709
Open Access | Times Cited: 24
CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding
Lexun Wang, Jiaojiao Feng, Yanyue Deng, et al.
Research (2022) Vol. 2022
Open Access | Times Cited: 22
Fufang Zhenzhu Tiaozhi capsule ameliorates hyperuricemic nephropathy by inhibition of PI3K/AKT/NF-κB pathway
Minghui Li, Jin Guan, Zhe Chen, et al.
Journal of Ethnopharmacology (2022) Vol. 298, pp. 115644-115644
Closed Access | Times Cited: 20
The role and therapeutic targeting of the CCL2/CCR2 signaling axis in inflammatory and fibrotic diseases
Shan Guo, Qi Zhang, Yingjie Guo, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Preventive Administration of Quercetin Promotes Survival and Reduces Adverse Ventricular Remodeling after myocardial infarction through facilitating M2-like macrophage polarization
Lexun Wang, Shaolin Lin, Quxing Wei, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114296-114296
Closed Access
Palmatine alleviates cardiac fibrosis by inhibiting fibroblast activation through the STAT3 pathway
Shaoling Lin, Shengxi Zhang, Angyu Zhan, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176395-176395
Closed Access | Times Cited: 3
Ameliorative potentials of the ethanolic extract from Lycium chinense leaf extract against diabetic cardiomyopathy. Insight into oxido-inflammatory and apoptosis modulation
Chaoling Wen, Chunhong Liu, Yetian Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113583-113583
Closed Access | Times Cited: 16
Integrative pharmacology reveals the mechanisms of Erzhi Pill, a traditional Chinese formulation, against diabetic cardiomyopathy
Mingming Peng, Tianyi Xia, Yanmei Zhong, et al.
Journal of Ethnopharmacology (2022) Vol. 296, pp. 115474-115474
Closed Access | Times Cited: 14
FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214 / SIRT3 signaling pathway
Yue Zhang, Mengxian Sun, Dongwei Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112696-112696
Open Access | Times Cited: 13
Paper title: Therapeutic effect of Momordica charantia on cardiomyopathy in a diabetic maternal rat model
Shaimaa Elnahas, Hend Abd El‐Halim Mansour, Mamdouh Rashad El-Sawi, et al.
Journal of Experimental Zoology Part A Ecological and Integrative Physiology (2024) Vol. 341, Iss. 9, pp. 977-990
Closed Access | Times Cited: 2
Fufang Zhenzhu Tiaozhi (FTZ) suppression of macrophage pyroptosis: Key to stabilizing rupture-prone plaques
Xiaoqi Shao, Wenru Zeng, Qing Wang, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117705-117705
Open Access | Times Cited: 1
A Review on the Natural Products in Treatment of Diabetic Cardiomyopathy (DCM)
Pengyu Yao, Xiaoni Yang, Yun Qiao
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 1
PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy
A Rostami, Xavier Palomer, Javier Pizarro‐Delgado, et al.
Pharmacological Research (2024) Vol. 210, pp. 107515-107515
Open Access | Times Cited: 1
The Effect of Eugenol Treatment on Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
Janti Qar, Bahaa Al‐Trad, Alaa khmaiseh, et al.
Biomedical & Pharmacology Journal (2022) Vol. 15, Iss. 2, pp. 623-633
Open Access | Times Cited: 6
Chinese medicine Fufang Zhenzhu Tiaozhi capsule ameliorates coronary atherosclerosis in diabetes mellitus-related coronary heart disease minipigs
Lexun Wang, Dongxing Zhang, Wenjing Zhan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113831-113831
Open Access | Times Cited: 6
Antidiabetic Activity of Hydromethanolic Extract of Crude Dorstenia barnimiana Root: Validation of In Vitro and In Vivo Antidiabetic and Antidyslipidemic Activity
Woretaw Sisay Zewdu, Yared Andargie Ferede, Mulugeta Molla
Journal of Experimental Pharmacology (2022) Vol. Volume 14, pp. 59-72
Open Access | Times Cited: 5
Lipoxin A4 prevents high glucose-induced inflammatory response in cardiac fibroblast through FOXO1 inhibition
Fabiola González‐Herrera, Renatto Anfossi, Mabel Catalán, et al.
Cellular Signalling (2023) Vol. 106, pp. 110657-110657
Closed Access | Times Cited: 2
The Traditional Chinese Medicine Formula FTZ Protects against Cardiac Fibrosis by Suppressing the TGFβ1-Smad2/3 Pathway
Yue Zhang, Dongwei Wang, Kaili Wu, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 3
Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis
Xiaoqi Shao, Bingying Huang, Huiling Tan, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 3
STAT protein family and cardiovascular diseases: overview of pathological mechanisms and therapeutic implications
Ghader Babaei, Samin Sadraei, Maral Yarahmadi, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Efficacy of traditional Chinese medicine on diabetic cardiomyopathy in animal models: a systematic review and meta-analysis
Longxiao Hu, Longxin Qian, Aochuan Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 1
Advances in the Pathogenesis and Treatment of MCP-1 in Diabetic Complications
珏 王
Advances in Clinical Medicine (2022) Vol. 12, Iss. 11, pp. 10856-10862
Closed Access | Times Cited: 1
Page 1

Scroll to top